Breast Cancer And Alcohol
Breast Cancer And Alcohol
By [http://ezinearticles.com/?expert=Mike_Vellucci]Mike Vellucci
Everyone has heard about the health benefits inherent to drinking red wine. While red wine may offer some benefits to the heart, little research exists involving alcohol's risk to breast cancer.
Although there is no direct evidence linking the two, current knowledge regarding the effects of alcohol implies the possibility of increasing risk. By nature, alcohol reduces the blood levels of folic acid. Folic acid is a B vitamin that fights against it. The folic acid reduction is a real worry for women who drink heavily as it could dramatically increase their risk.
There are a variety of ways in which folic acid can be replenished to combat the effects of alcohol. One obvious solution is to take a multivitamin or folic acid tablet. Additionally, there are many foods which contain folic acid. Many great vegetables, such as spinach, asparagus, broccoli, and split peas are rich in folic acid. Beans are also a good source of folic acid.
Beyond folic acid depletion, preliminary research
Estrogen for Triple Negative Breast Cancer
<b>Condition</b>: Female Breast Cancer<br/><b>Intervention</b>: Drug: Estradiol<br/><b>Sponsor</b>: University of Wisconsin, Madison<br/><b>Recruiting</b> - verified March 2010
Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer
<b>Conditions</b>: Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer<br/><b>Interventions</b>: Drug: vorinostat; Drug: ixabepilone<br/><b>Sponsor</b>: City of Hope Medical Center<br/><b>Not yet recruiting</b> - verified March 2010
Female Cancer Patients' Preference For Sexual Health Interventions
<b>Conditions</b>: Breast Cancer; Gynecologic Cancer<br/><b>Intervention</b>: <br/><b>Sponsor</b>: Memorial Sloan-Kettering Cancer Center<br/><b>Recruiting</b> - verified March 2010
Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery
<b>Condition</b>: Breast Cancer<br/><b>Interventions</b>: Other: laboratory biomarker analysis; Other: questionnaire administration; Procedure: adjuvant therapy; Radiation: 3-dimensional conformal accelerated partial breast irradiation<br/><b>Sponsors</b>: Radiation Therapy Oncology Group; National Cancer Institute (NCI)<br/><b>Not yet recruiting</b> - verified March 2010
Study of XL147 or XL765 in Combination With Letrozole in Subjects With Breast Cancer
<b>Condition</b>: Breast Cancer<br/><b>Interventions</b>: Drug: XL147; Drug: XL765; Drug: letrozole (Femara)<br/><b>Sponsor</b>: Exelixis<br/><b>Not yet recruiting</b> - verified March 2010
Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment Adherence
<b>Condition</b>: Breast Cancer<br/><b>Intervention</b>: <br/><b>Sponsor</b>: AstraZeneca<br/><b>Not yet recruiting</b> - verified March 2010
89Zr-trastuzumab PET for Imaging the Effect of HSP90 Inhibition
<b>Condition</b>: Breast Cancer<br/><b>Intervention</b>: Other: Imaging with 89Zr-trastuzumab PET<br/><b>Sponsor</b>: University Medical Centre Groningen<br/><b>Recruiting</b> - verified February 2010
Evaluating the Age Extension of the NHS Breast Screening Programme
<b>Condition</b>: Breast Cancer Mortality<br/><b>Intervention</b>: Other: Invitation for breast screening<br/><b>Sponsors</b>: University of Oxford; Department of Health, United Kingdom<br/><b>Not yet recruiting</b> - verified March 2010
Imaging HSP90 Inhibitor AUY922 on VEGF-89ZR-bevacizumab PET
<b>Condition</b>: Breast Cancer<br/><b>Intervention</b>: Other: 89Zr-bevacizumab PET imaging<br/><b>Sponsor</b>: University Medical Centre Groningen<br/><b>Recruiting</b> - verified February 2010
The Effect of Aromatase Inhibitors on Cardiovascular Risk Factors in Women With Breast Cancer
<b>Condition</b>: Breast Cancer<br/><b>Intervention</b>: <br/><b>Sponsors</b>: University of Pittsburgh; National Center for Research Resources (NCRR)<br/><b>Recruiting</b> - verified March 2010
A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer
<b>Condition</b>: Neutropenia in Breast Cancer<br/><b>Interventions</b>: Drug: Filgrastim (Eurofarma); Drug: Filgrastim (Granulokine, Amgen)<br/><b>Sponsor</b>: Eurofarma Laboratorios Ltda<br/><b>Not yet recruiting</b> - verified March 2010
Letrozole in Treating Healthy Postmenopausal Women at High Risk for Breast Cancer
<b>Condition</b>: Breast Cancer<br/><b>Intervention</b>: Drug: letrozole<br/><b>Sponsors</b>: University of Arizona; National Cancer Institute (NCI)<br/><b>Not yet recruiting</b> - verified February 2010
Brain Metastasis in Breast Cancer Patients
<b>Condition</b>: Breast Cancer<br/><b>Intervention</b>: Drug: Trastuzumab or Lapatinib<br/><b>Sponsor</b>: GlaxoSmithKline<br/><b>Active, not recruiting</b> - verified February 2010
Study of Tamoxifen Dose Escalation in Breast Cancer Patients With CYP2D6 Polymorphisms
<b>Conditions</b>: Breast Cancer; CYP2D6 Polymorphism<br/><b>Intervention</b>: Drug: Tamoxifen<br/><b>Sponsor</b>: Sydney West Area Health Service<br/><b>Not yet recruiting</b> - verified February 2010
Prevention of Capsular Contracture Using Trental and Vitamin E
<b>Condition</b>: Capsular Contractures<br/><b>Intervention</b>: Drug: Trental<br/><b>Sponsor</b>: Legacy Health System<br/><b>Recruiting</b> - verified March 2010
Lymph Fluid and Blood Collection for Identification of Novel Biomarkers
<b>Condition</b>: Adenocarcinoma of the Breast<br/><b>Intervention</b>: <br/><b>Sponsor</b>: Indiana University<br/><b>Not yet recruiting</b> - verified February 2010
Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats
<b>Conditions</b>: Ovarian; Breast; Prostate; Pancreatic; Advanced Tumours<br/><b>Intervention</b>: Drug: olaparib<br/><b>Sponsor</b>: AstraZeneca<br/><b>Recruiting</b> - verified March 2010
Carcinogenicity Study of Bupropion
<b>Conditions</b>: Depressive Disorder; Cancer<br/><b>Interventions</b>: Drug: Regular bupropion use; Drug: Regular SSRI (Selective serotonin reuptake inhibitors) use; Drug: Regular use of any other antidepressant; Drug: Regular TCA (Tricyclic antidepressants) use<br/><b>Sponsor</b>: GlaxoSmithKline<br/><b>Active, not recruiting</b> - verified February 2010
Pilot Pharmacokinetic Study of Daily Versus Monthly High-Dose Cholecalciferol Supplementation
<b>Condition</b>: Healthy Volunteers<br/><b>Interventions</b>: Dietary Supplement: Single High Dose Cholecalciferol; Dietary Supplement: Daily Dose Cholecalciferol<br/><b>Sponsor</b>: Mayo Clinic<br/><b>Recruiting</b> - verified March 2010
suggests another possible detrimental link between and alcohol. The healthful plant chemicals found in wine, called phenols, could attach to estrogen receptors on breast cells. This cell attachment could potentially fuel the growth of the cancer.
While alcohol, such as red wine, may offer some health benefits, research still needs to be conducted to understand any possible cancer risks. In order to reduce any possible alcohol induced risk, it is important to drink only in moderation. For more information about this and other information please visit http://help4breastcancer.com
This Article is written by Mike Vellucci. For more information about please visit http://help4breastcancer.com
Article Source: http://EzineArticles.com/?expert=Mike_Vellucci http://EzineArticles.com/?Breast-Cancer-And-Alcohol&id=848199
|
